Introduction
kidneys. High levels of AT 2 receptors and mRNA expression have been demonstrated in the macula Angiotensin II (Ang II ), the physiologically active densa of ovine fetal kidney, suggesting a potential role component of the renin-angiotensin system, plays an of AT 2 receptors in the development of this structure important role in the regulation of the cardiovascular [10] . Nishimura et al.
[11] also reported the involveand renal systems. Based on their different pharmacoment of AT 2 receptors in the formation of the embrylogical and biochemical properties, two distinct subonic ureter by the promotion of the mesenchymal cell types of Ang II receptor have been defined and desigapoptosis. In contrast, the expression of AT 2 receptors nated as type 1 (AT 1 ) and type 2 (AT 2 ) receptors. in the adult mammalian kidney has been reported to While both AT 1 and AT 2 receptors belong to the sevenbe very low, and localized mainly in the glomerular transmembrane, G-protein-coupled receptor family, mesangial cells [12, 13] or adventitia of the preglomerthe function and signalling mechanism of these receptor ular arcuate and interlobular arteries [14] . However, subtypes are quite different [ [9] . In this article, we will summarize results tor may be re-expressed in the adult kidney in response obtained from recent studies on the AT 2 receptor-to Ang II and may mediate renal vasodilatation and/or mediated action of Ang II in the kidney, together with inhibition of tubular sodium reabsorption by stimulatother relevant literature. Only a limited number of ing bradykinin, NO, and/or eicosanoid production. references are given.
However, a potential renal tubular action of the AT 2 receptor is still controversial. Lo et al. [19] 
and antihypertensive effects partly through AT 2 recep-AT 2 receptors are coupled to the NO/bradykinin pathway, which plays a counter-regulatory protective role tor activation, because treatment with AT 1 receptor antagonists elevates plasma levels of Ang II [26 ] , which against the AT 1 receptor-mediated pressor actions of Ang II [8] . The reason for this discrepancy between preferentially binds to AT 2 receptor. Further understanding of the renal AT 2 receptor function may conour results and theirs is unclear; however, it may be related to the origin of NO measured in their study. tribute to new therapeutic strategies of AT 1 receptor antagonists for renal diseases and hypertension. Within the kidney NO is produced not only by the vascular endothelium but also by several tubular segments including the macula densa [20, 21] . Thus, it is 
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